Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales: 2019-2024

Historic Return on Sales for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to -0.10%.

  • Eton Pharmaceuticals' Return on Sales fell 3.00% to -0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.12%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.10% for FY2024, which is 7.00% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Return on Sales stood at -0.10% for FY2024, which was down 231.29% from -0.03% recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Return on Sales high stood at -0.03% for FY2023, and its period low was -717.18% during FY2020.
  • For the 3-year period, Eton Pharmaceuticals' Return on Sales averaged around -0.18%, with its median value being -0.10% (2024).
  • Per our database at Business Quant, Eton Pharmaceuticals' Return on Sales plummeted by 69,808bps in 2020 and then surged by 71,709bps in 2021.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Sales (Yearly) stood at -717.18% in 2020, then soared by 71,709bps to -0.09% in 2021, then slumped by 33bps to -0.42% in 2022, then surged by 39bps to -0.03% in 2023, then dropped by 7bps to -0.10% in 2024.